Clinical Trial Details
| Trial ID: | L5737 |
| Source ID: | NCT04322032 |
| Associated Drug: | Reference Drug |
| Title: | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-389 |
| Acronym: | |
| Status: | UNKNOWN |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes |
| Interventions: | DRUG: Reference drug|DRUG: Test drug |
| Outcome Measures: | Primary: AUCt(Area Under Curve last), Area under the plasma concentration time curve of CKD-389/D759\&D308, from time zero up to the last measurable concentration., Each period: Pre-dose (0 hour), post-dose 0.17, 0.33, 0.5, 0.75, 1, 1.5, 2, 2.5, 3, 4, 6, 8, 12, 24, 48 h|Cmax, The maximum concentration observed of CKD-389/D759\&D308 over blood sampling time., Each period: Pre-dose (0 hour), post-dose 0.17, 0.33, 0.5, 0.75, 1, 1.5, 2, 2.5, 3, 4, 6, 8, 12, 24, 48 h | |
| Sponsor/Collaborators: | Sponsor: Chong Kun Dang Pharmaceutical |
| Gender: | ALL |
| Age: | ADULT |
| Phases: | PHASE1 |
| Enrollment: | 34 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2020-04-06 |
| Completion Date: | 2020-05-18 |
| Results First Posted: | |
| Last Update Posted: | 2020-03-26 |
| Locations: | Chonbuk National University Hospital, Jeonju, Korea, Republic of |
| URL: | https://clinicaltrials.gov/show/NCT04322032 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|